• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Gen Med . Clinical Characteristics and Predictors of Mortality in Patients with COVID-19 Infection Outside Intensive Care

tetano

Editor, Senior Moderator
Int J Gen Med


. 2020 Nov 17;13:1157-1165.
doi: 10.2147/IJGM.S271432. eCollection 2020.
Clinical Characteristics and Predictors of Mortality in Patients with COVID-19 Infection Outside Intensive Care


Saadiq M Moledina[SUP] #[/SUP][SUP] 1 [/SUP], Alexander A Maini[SUP] #[/SUP][SUP] 1 [/SUP], Alice Gargan[SUP] 1 [/SUP], William Harland[SUP] 1 [/SUP], Heloise Jenney[SUP] 1 [/SUP], Georgina Phillips[SUP] 1 [/SUP], Kate Thomas[SUP] 1 [/SUP], Devkishan Chauhan[SUP] 1 [/SUP], Michael Fertleman[SUP] 1 [/SUP]



Affiliations

Abstract

Background/introduction: The coronavirus disease 2019 (COVID-19) pandemic has affected all aspects of inpatient hospital medicine with patients admitted from level 1 (general medical wards) to level 3 (intensive care). Often, there are subtle physiological differences in these cohorts of patients. In particular, in intensive care, patients tend to be younger and have increased disease severity. Data, to date, has combined outcomes from medical and intensive care cohorts, or looked exclusively at intensive care. We looked solely at the level 1 (medical) cohort to identify their clinical characteristics and predictors of outcome.
Patients and methods: This was a retrospective study of adult patients admitted to a central London teaching hospital with a diagnosis of COVID-19 from 23rd March to 7th April 2020 identified from the hospital electronic database. Any patients who required level 2 or 3 care were excluded.
Results: A total of 229 patients were included for analysis. Increased age and frailty scores were associated with increased 30-day mortality. Reduced renal function and elevated troponin blood levels are also associated with poor outcome. Baseline observations showed that increased oxygen requirement was predictive for mortality. A trend of increased mortality with lower diastolic blood pressure was noted. Lymphopenia was not shown to be related to mortality.
Conclusion: Urea and creatinine are the best predictors of mortality in the level 1 cohort. Unlike previous intensive care data, lymphopenia is not predictive of mortality. We suggest that these factors be considered when prognosticating and for resource allocation for the treatment and escalation of care for patients with COVID-19 infection.

Keywords: COVID-19; ICU; frailty; lymphopenia; mortality; renal dysfunction.
 
Back
Top Bottom